Literature DB >> 27795360

Local Induction of B Cell Interleukin-10 Competency Alleviates Inflammation and Bone Loss in Ligature-Induced Experimental Periodontitis in Mice.

Pei Yu1,2, Yang Hu2, Zhiqiang Liu2,3, Toshihisa Kawai2, Martin A Taubman2, Wei Li1, Xiaozhe Han4.   

Abstract

Interleukin-10 (IL-10)-producing B cells (B10 cells) play a critical role in the immune system balance by negatively regulating inflammatory responses. This study was conducted to determine the effect of local B10 cell induction on periodontal inflammation and bone loss in ligature-induced experimental periodontitis in vivo Purified spleen B cells from C57BL/6J mice (8 to 10 weeks old) were cultured with CD40 ligand (CD40L) and the Toll-like receptor 9 (TLR9) agonist cytidine-phosphate-guanosine oligodeoxynucleotide (CpG) to determine effective IL-10 induction in vitro Silk ligatures (size 7-0) were tied around the mouse maxillary second molars on day 0, followed by the injection of CD40L and CpG into the palatal gingiva on days 3, 6, and 9. All the mice were sacrificed, and samples were collected on day 14. CD40L and CpG significantly increased the level of IL-10 production by B cells in vitro, although the frequencies of CD1dhi CD5+ and IL-10-producing (IL-10+) CD45+ cells were decreased. IL-10 was predominantly produced by the CD1dhi CD5+ subpopulation of B cells. In vivo, both IL-10 mRNA expression and the number of IL-10+ CD45+ cells were significantly increased after gingival injection of CD40L and CpG. Periodontal bone loss was significantly decreased and the gingival expression of IL-1β, tumor necrosis factor alpha, and RANKL was significantly reduced. The number of multinucleated tartrate-resistant acid phosphatase-positive cells along the alveolar bone surface was significantly decreased after gingival injection of CD40L and CpG. This study indicates for the first time that the local induction of B10 cell activity could inhibit periodontal inflammation and bone loss.
Copyright © 2016 American Society for Microbiology.

Entities:  

Keywords:  B cells; IL-10; RANKL; bone resorption; periodontitis

Mesh:

Substances:

Year:  2016        PMID: 27795360      PMCID: PMC5203658          DOI: 10.1128/IAI.00645-16

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

Review 1.  A case for regulatory B cells.

Authors:  Atsushi Mizoguchi; Atul K Bhan
Journal:  J Immunol       Date:  2006-01-15       Impact factor: 5.422

2.  Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis.

Authors:  Takashi Matsushita; Mayuka Horikawa; Yohei Iwata; Thomas F Tedder
Journal:  J Immunol       Date:  2010-07-12       Impact factor: 5.422

Review 3.  CD40-CD40 ligand.

Authors:  C van Kooten; J Banchereau
Journal:  J Leukoc Biol       Date:  2000-01       Impact factor: 4.962

4.  Tim-1 is essential for induction and maintenance of IL-10 in regulatory B cells and their regulation of tissue inflammation.

Authors:  Sheng Xiao; Craig R Brooks; Raymond A Sobel; Vijay K Kuchroo
Journal:  J Immunol       Date:  2015-01-12       Impact factor: 5.422

5.  Toll-Like Receptor 9-Mediated Inflammation Triggers Alveolar Bone Loss in Experimental Murine Periodontitis.

Authors:  Paul D Kim; Xia Xia-Juan; Katie E Crump; Toshiharu Abe; George Hajishengallis; Sinem E Sahingur
Journal:  Infect Immun       Date:  2015-05-11       Impact factor: 3.441

6.  Positive selection of B10 cells is determined by BCR specificity and signaling strength.

Authors:  Jigang Zhang; Ming Wan; Jing Ren; Jixin Gao; Meng Fu; Gang Wang; Yufeng Liu; Wei Li
Journal:  Cell Immunol       Date:  2016-04-23       Impact factor: 4.868

7.  Discordant protein and mRNA expression in lung adenocarcinomas.

Authors:  Guoan Chen; Tarek G Gharib; Chiang-Ching Huang; Jeremy M G Taylor; David E Misek; Sharon L R Kardia; Thomas J Giordano; Mark D Iannettoni; Mark B Orringer; Samir M Hanash; David G Beer
Journal:  Mol Cell Proteomics       Date:  2002-04       Impact factor: 5.911

8.  A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses.

Authors:  Koichi Yanaba; Jean-David Bouaziz; Karen M Haas; Jonathan C Poe; Manabu Fujimoto; Thomas F Tedder
Journal:  Immunity       Date:  2008-05       Impact factor: 31.745

Review 9.  IL-10-producing regulatory B cells (B10 cells) in autoimmune disease.

Authors:  Ioannis Kalampokis; Ayumi Yoshizaki; Thomas F Tedder
Journal:  Arthritis Res Ther       Date:  2013-02-11       Impact factor: 5.156

10.  Prevention of arthritis by interleukin 10-producing B cells.

Authors:  Claudia Mauri; David Gray; Naseem Mushtaq; Marco Londei
Journal:  J Exp Med       Date:  2003-02-17       Impact factor: 14.307

View more
  14 in total

1.  MicroRNA-146a regulates the production of cytokines in lymphocytes stimulated by Porphyromonas gingivalis lipopolysaccharide.

Authors:  Yu-Ting Si; Jin-Hua Song; Zhen Fang; Xiao-Zhe Han; Shao-Yun Jiang
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2021-02-01

2.  IL-10 Dampens an IL-17-Mediated Periodontitis-Associated Inflammatory Network.

Authors:  Lu Sun; Mustafa Girnary; Lufei Wang; Yizu Jiao; Erliang Zeng; Kyle Mercer; Jinmei Zhang; Julie T Marchesan; Ning Yu; Kevin Moss; Yu L Lei; Steven Offenbacher; Shaoping Zhang
Journal:  J Immunol       Date:  2020-03-13       Impact factor: 5.422

3.  miR-146a regulates inflammatory cytokine production in Porphyromonas gingivalis lipopolysaccharide-stimulated B cells by targeting IRAK1 but not TRAF6.

Authors:  Shaoyun Jiang; Yang Hu; Shu Deng; Jiayin Deng; Xinbo Yu; Grace Huang; Toshihisa Kawai; Xiaozhe Han
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-12-27       Impact factor: 5.187

4.  OC-STAMP promotes osteoclast fusion for pathogenic bone resorption in periodontitis via up-regulation of permissive fusogen CD9.

Authors:  Takenobu Ishii; Montserrat Ruiz-Torruella; Atsushi Ikeda; Satoru Shindo; Alexandru Movila; Hani Mawardi; Abdullah Albassam; Rayyan A Kayal; Ayman A Al-Dharrab; Kenji Egashira; Wichaya Wisitrasameewong; Kenta Yamamoto; Abdulghani I Mira; Kenji Sueishi; Xiaozhe Han; Martin A Taubman; Takeshi Miyamoto; Toshihisa Kawai
Journal:  FASEB J       Date:  2018-03-13       Impact factor: 5.191

5.  In vitro and in vivo study of the pathogenic role of PPARα in experimental periodontitis.

Authors:  Ying Chen; Zheqing Jiang; Ana Keohane; Yang Hu
Journal:  J Appl Oral Sci       Date:  2022-07-08       Impact factor: 3.144

6.  Cytidine-phosphate-guanosine oligodeoxynucleotides in combination with CD40 ligand decrease periodontal inflammation and alveolar bone loss in a TLR9-independent manner.

Authors:  Qian Zhao; Yang Hu; Shu Deng; Pei Yu; Bowen Chen; Zuomin Wang; Xiaozhe Han
Journal:  J Appl Oral Sci       Date:  2018-05-21       Impact factor: 2.698

7.  B cell subset distribution is altered in patients with severe periodontitis.

Authors:  Julien Demoersman; Pierre Pochard; Camille Framery; Quentin Simon; Sylvie Boisramé; Assem Soueidan; Jacques-Olivier Pers
Journal:  PLoS One       Date:  2018-02-15       Impact factor: 3.240

8.  In-vivo imaging revealed antigen-directed gingival B10 infiltration in experimental periodontitis.

Authors:  Yufeng Wang; Yang Hu; Keqing Pan; Hao Li; Shu Shang; Yuhua Wang; Guoyao Tang; Xiaozhe Han
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-10-17       Impact factor: 5.187

9.  Omentin-1 prevents inflammation-induced osteoporosis by downregulating the pro-inflammatory cytokines.

Authors:  Shan-Shan Rao; Yin Hu; Ping-Li Xie; Jia Cao; Zhen-Xing Wang; Jiang-Hua Liu; Hao Yin; Jie Huang; Yi-Juan Tan; Juan Luo; Ming-Jie Luo; Si-Yuan Tang; Tuan-Hui Chen; Ling-Qing Yuan; Er-Yuan Liao; Ran Xu; Zheng-Zhao Liu; Chun-Yuan Chen; Hui Xie
Journal:  Bone Res       Date:  2018-03-30       Impact factor: 13.567

Review 10.  Toll-Like Receptor Signaling and Immune Regulatory Lymphocytes in Periodontal Disease.

Authors:  Yingzhi Gu; Xiaozhe Han
Journal:  Int J Mol Sci       Date:  2020-05-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.